Effectiveness of expanded hemodialysis (HDx) in Colombia: A retrospective clinical outcomes study

Renal Therapy Services0 sites1,098 target enrollmentAugust 13, 2020

Overview

2022 Results article in https://doi.org/10.1016/j.xkme.2022.100431 medium cutoff (MCO) versus high-flux (HF) dialysis membranes results (added 23/02/2022)

Registry

who.int

Start Date

August 13, 2020

End Date

December 31, 2020

Last Updated

4 years ago

Study Type

Observational

Sex

All

Sponsor

Renal Therapy Services

•1\. End stage renal disease
•2\. Prevalent HD patient defined as having received HD for 90 days or more at the time of the cohort’s inception (01 September 2017 through 30 November 2017\)
•3\. Enrolled in the COREXH registry between 01 September 2017 and 30 November 2017, or were treated via conventional high\-flux HD during the same time period at the same renal centers, and with the same model of dialysis care
•4\. Undergoing HD at least 3 times per week and a minimum duration of 4 hours per session
•5\. Received dialysis treatment in a renal clinic that meets water quality standards established by the Association for the Advancement of Medical Instrumentation (AAMI)

•1\. High comorbidity measured as Charlson comorbidity Index \> 8 and patients who were not expected to survive 6 months
•2\. Metastatic disease
•3\. Pregnancy
•4\. Younger than 18 years old